Source: Annual Congress 2004 - Role of infection in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Mallia, T. Kebadze, S. Message, S. Johnston (London, United Kingdom). An experimental model of rhinovirus-induced COPD exacerbation. Eur Respir J 2004; 24: Suppl. 48, 4203

Member's Comments

No comment yet.

Related content which might interest you: Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 The character of COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 34s Year: 2006 IL-18 in infectious exacerbations of COPD Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 An evaluation of exacerbations in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Antibiotics in acute exacerbation of asthma and COPD Source: Eur Respir Monogr 2017; 75: 150-158 Year: 2017 Prediction models for exacerbations in patients with COPD Source: Eur Respir Rev 2017; 26: 160061 Year: 2017 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Catabolic/anabolic balance in patients with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Modelling exacerbations of COPD Source: Annual Congress 2012 - Modelling respiratory infections: is it the future or the present? Year: 2012 Change in inflammation during COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 15s Year: 2005 Bacterial burden in rhinovirus-induced asthma exacerbations Source: Lung Science Conference 2015 Year: 2015 Comparison of fluticasone, roflumilast and tiotropium in a model of influenza-induced acute COPD exacerbation Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020